These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20918978)

  • 41. An integrative structure-based framework for predicting biological effects mediated by antipeptide antibodies.
    Caoili SE
    J Immunol Methods; 2015 Dec; 427():19-29. PubMed ID: 26410103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phylogenetic origins of antibody structure. I. Multichain structure of immunoglobulins in the smooth dogfish (Mustelus canis).
    Marchalonis J; Edelman GM
    J Exp Med; 1965 Sep; 122(3):601-18. PubMed ID: 4158437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies against haptens in the study of structure and biological activity of growth hormone.
    Nowicki C; Santomé JA
    Int J Pept Protein Res; 1979 Apr; 13(4):379-84. PubMed ID: 222700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Affinity chromatographic separation of gonadotropic hormone agonist and antagonist antibodies. Implications for structure, immunological and biological properties of glycoproteins.
    Sairam MR; Jiang LG
    J Chromatogr; 1992 Jun; 604(1):171-6. PubMed ID: 1639924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Location of amino acid residues important for the structure and biological function of the haemagglutinin-neuraminidase glycoprotein of Sendai virus by analysis of escape mutants.
    Lyn D; Mazanec MB; Nedrud JG; Portner A
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():817-24. PubMed ID: 1849969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity.
    Soos MA; Field CE; Lammers R; Ullrich A; Zhang B; Roth RA; Andersen AS; Kjeldsen T; Siddle K
    J Biol Chem; 1992 Jun; 267(18):12955-63. PubMed ID: 1377676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies.
    Melloni J
    Am Fam Physician; 1976 May; 13(5):105. PubMed ID: 1274804
    [No Abstract]   [Full Text] [Related]  

  • 48. [Structure-function relationship of glycoprotein hormone].
    Endo Y
    Rinsho Byori; 1990 Oct; 38(10):1149-54. PubMed ID: 1702167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of monoclonal antibodies in the study of intestinal structure and function.
    Quaroni A
    Ciba Found Symp; 1983; 95():113-31. PubMed ID: 6342993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phylogeny of immunoglobulin structure and function. V. Valences and association constants of teleost antibodies to a haptenic determinant.
    Clem LW; Small PA
    J Exp Med; 1970 Sep; 132(3):385-400. PubMed ID: 4109109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-function relationship: biological activities of the lipopolysaccharides and lipid A from Vibrio cholerae.
    Raziuddin S
    J Infect Dis; 1979 Oct; 140(4):590-5. PubMed ID: 512418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production and characterization of antibodies to gonadotropin-releasing hormone receptor.
    Hazum E; Schvartz I; Popliker M
    J Biol Chem; 1987 Jan; 262(2):531-4. PubMed ID: 3027055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Receptors for biologically active substances in the light of the studies using monoclonal antibodies].
    Lipski S
    Postepy Hig Med Dosw; 1989; 43(2-4):161-97. PubMed ID: 2562034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of monoclonal antibodies in studies of lipoprotein structure and function.
    Schonfeld G; Tikkanen MJ; Hahm KS
    Adv Exp Med Biol; 1985; 183():135-57. PubMed ID: 2412411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antipeptide antibodies of predetermined specificity recognize and neutralize the bioactivity of the pan-specific hemopoietin interleukin 3.
    Ziltener HJ; Clark-Lewis I; Hood LE; Kent SB; Schrader JW
    J Immunol; 1987 Feb; 138(4):1099-104. PubMed ID: 2433340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibodies as probes of structure, function and isoenzyme forms of the type II regulatory subunit of cyclic AMP-dependent protein kinase.
    Mumby MC; Weldon SL; Scott CW; Taylor SS
    Pharmacol Ther; 1985; 28(3):367-87. PubMed ID: 2418450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimally stable nanoparticle-based colorimetric assay for simple, rapid, and sensitive antibody structure and activity evaluation.
    Woo JR; Lim DK; Nam JM
    Small; 2011 Mar; 7(5):648-55. PubMed ID: 21308990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catalytic antibodies: structure and function.
    Wentworth P; Janda KD
    Cell Biochem Biophys; 2001; 35(1):63-87. PubMed ID: 11898856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From esoteric theory to therapeutic antibodies.
    Wu TT
    Appl Biochem Biotechnol; 1994; 47(2-3):107-17; discussion 17-8. PubMed ID: 7944331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Preparation of 125I-labelled monoclonal antibodies of the insulin receptor].
    Sesti G; Marini MA; Montemurro A; Di Daniele N; Bertoli A; Cordera R; Andraghetti G; De Pirro R; Lauro R; Monaco F
    C R Seances Soc Biol Fil; 1988; 182(2):167-76. PubMed ID: 2973824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.